Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
100%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Completed1
Terminated1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed125%
terminated125%
recruiting125%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
terminatednot_applicable

Study of OMNI Surgical System and iStent for Eyes With OAG (Trident)

NCT04658095
recruitingnot_applicable

GATT Versus Canaloplasty (GVC)

NCT05366647
completednot_applicable

Trabeculectomy Versus Canaloplasty

NCT01228799
unknownnot_applicable

Trabeculectomy Versus Canaloplasty to Treat Glaucoma

NCT00854256

Clinical Trials (4)

Showing 4 of 4 trials
NCT04658095Not Applicable

Study of OMNI Surgical System and iStent for Eyes With OAG (Trident)

Terminated
NCT05366647Not Applicable

GATT Versus Canaloplasty (GVC)

Recruiting
NCT01228799Not Applicable

Trabeculectomy Versus Canaloplasty

Completed
NCT00854256Not Applicable

Trabeculectomy Versus Canaloplasty to Treat Glaucoma

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4